Ladenburg Thalmann Financial Services’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $0 | Sell |
182
-5,073
| -97% | – | ﹤0.01% | 5416 |
|
|
2019
Q3 | $5K | Hold |
5,255
| – | – | ﹤0.01% | 4687 |
|
|
2019
Q2 | $6K | Hold |
5,255
| – | – | ﹤0.01% | 4643 |
|
|
2019
Q1 | $7K | Buy |
5,255
+255
| +5% | +$340 | ﹤0.01% | 4532 |
|
|
2018
Q4 | $5K | Sell |
5,000
-715
| -13% | -$715 | ﹤0.01% | 4596 |
|
|
2018
Q3 | $12K | Hold |
5,715
| – | – | ﹤0.01% | 4185 |
|
|
2018
Q2 | $13K | Hold |
5,715
| – | – | ﹤0.01% | 4096 |
|
|
2018
Q1 | $13K | Hold |
5,715
| – | – | ﹤0.01% | 4096 |
|
|
2017
Q4 | $11K | Hold |
5,715
| – | – | ﹤0.01% | 4134 |
|
|
2017
Q3 | $14K | Buy |
+5,715
| New | +$14K | ﹤0.01% | 3891 |
|
|
2017
Q1 | – | Sell |
-457
| Closed | -$1K | – | 4913 |
|
|
2016
Q4 | $1K | Sell |
457
-486
| -52% | -$1.06K | ﹤0.01% | 4669 |
|
|
2016
Q3 | $4K | Hold |
943
| – | – | ﹤0.01% | 4266 |
|
|
2016
Q2 | $2K | Buy |
943
+457
| +94% | +$969 | ﹤0.01% | 4406 |
|
|
2016
Q1 | $1K | Sell |
486
-41
| -8% | -$84 | ﹤0.01% | 4528 |
|
|
2015
Q4 | $2K | Hold |
527
| – | – | ﹤0.01% | 4359 |
|
|
2015
Q3 | $1K | Hold |
527
| – | – | ﹤0.01% | 4426 |
|
|
2015
Q2 | $2K | Hold |
527
| – | – | ﹤0.01% | 4355 |
|
|
2015
Q1 | $2K | Hold |
527
| – | – | ﹤0.01% | 4280 |
|
|
2014
Q4 | $2K | Hold |
527
| – | – | ﹤0.01% | 4056 |
|
|
2014
Q3 | $1K | Buy |
+527
| New | +$1K | ﹤0.01% | 3802 |
|
|
2014
Q2 | – | Sell |
-496
| Closed | -$1K | – | 3933 |
|
|
2014
Q1 | $1K | Sell |
496
-495
| -50% | -$998 | ﹤0.01% | 3635 |
|
|
2013
Q4 | $3K | Hold |
991
| – | – | ﹤0.01% | 3414 |
|
|
2013
Q3 | $3K | Hold |
991
| – | – | ﹤0.01% | 3348 |
|
|
2013
Q2 | $3K | Buy |
+991
| New | +$3K | ﹤0.01% | 3231 |
|